Ros, Javier

Universitat Autònoma de Barcelona · Vall d'Hebron Hospital Universitari · Vall d'Hebron Institute of Oncology

2 papers on CoChatORCID 0000-0002-8137-5415

Most cited papers

Verified
Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies
Vaghi, C., Tosi, F., Mauri, G., Bonazzina, E., Amatu, A., Bencardino, K., Piscazzi, D., Roazzi, L., Villa, F., Maggi, M., et al. (2026) · Drugs
Colorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research
Cited by 11
Verified
Impact of immune-related adverse events on survival in patients with metastastic urothelial carcinoma treated with immune-checkpoint inhibitors.
Morales-Barrera, R., Suarez Rodriguez, C., Gonzalez, M., Ros, J., Semidey, M. E., Serra Hernandez, E., Mateo, J., Fernández Sáez, C., Lozano, F., Mast, R., et al. (2019) · Journal of Clinical Oncology
Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments
Cited by 10

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free